Wednesday March 13, 2019 0 comments
ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced the expansion of its corporate headquarters building footprint to 63,000 square feet, a 50 percent increase.
"Our order and revenue growth has put pressure on expanding our corporate headquarters and we are fortunate to have a Right of First Refusal to add additional space with our existing building,” said Thomas Sandgaard, Zynex CEO.
“We moved in a year ago and already in need of more square footage due to expanding shipments and employee additions. We are well prepared for future growth as we continue to add sales representatives across the country at a rapid rate."
Founded in 1996, Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.
Zynex said it is also developing a new blood volume monitor for use in hospitals and surgery centers.